10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Renuka Iyer, MD, Appointed Chief Medical Officer of the National Comprehensive Cancer Network
FDA Issues 81 New Product-Specific Guidances to Advance Generic Drug Development
Pat Soon-Shiong: Grateful to Sean and Ryan for Bringing Awareness that with Lymphocytes, Patients Have a Better Chance of Beating Cancer
Treatment Outcomes With Amivantamab–Lazertinib in EGFR Mutant NSCLC: CHRYSALIS-2 Trial
Francis deSouza: Say Hello to Gemini 3
Paradigm Health has Acquired Flatiron Health’s Clinical Research Business
The First Non-Imaging, Blood-Based Test Designed to Detect Breast Cancer - Astrin Biosciences
